logo-loader

Creo Medical Group FY22 results and recent funding - Proactive Research Analyst

Published: 11:10 27 Apr 2023 EDT

Proactive Research Analyst John Savin gives the highlights from his latest research note on UK-based medical device company Creo Medical Group PLC (AIM:CREO)

Savin talks about the company's recent performance and key products, before moving on to look at how it is positioned for the future.

He also touches on a recent placing that generated a net £32 million.

Click here to read the report

Alvopetro posts 86% net back margin as Q2 volumes jump 26% and Murucututu...

Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF, FRA:A6Y0) CEO Corey Ruttan tells Proactive's Stephen Gunnion that Q2 2026 sales volumes averaged 3,067 barrels of oil equivalent per day, up 26% year-on-year, with revenue of just over $19 million and funds flow from operations of $14.1...

22 hours, 57 minutes ago